Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
2 papers
Anxiety disorders are a group of conditions marked by persistent, excessive fear or worry and behaviors (like avoidance) that cause real trouble in daily life. They are the most common class of psychiatric disorder — large surveys report that up to 33.7% of people will have one in their lifetime…
Researchers reviewed published clinical trials testing psychedelic drugs for people diagnosed with anxiety disorders. They found nine trials that used ayahuasca, ketamine, LSD, MDMA, or psilocybin. Overall, the studies showed reduced anxiety symptoms and better self-image or social functioning for people with generalized anxiety, social anxiety, or anxiety linked to…
